United Therapeutics stock is quoted on the NASDAQ Global Select Market under the ticker symbol "UTHR". You may purchase shares of United Therapeutics stock through a licensed stockbroker or fianancial advisor.
We do not have access to individual account information. Shareholders with inquiries about share count, address corrections, lost certificates, or changes in registered share ownership should first contact their stockbroker or financial advisor. If additional assistance is needed, shareholders may also contact United Therapeutics' stock transfer agent:
Mailing Address:
Computershare
P.O. Box 43006
Providence, RI 02940-3006
Overnight Correspondence Address:
Computershare
P.O. Box 43006
Providence, RI 02940-3006
Website: www.computershare.com/investor
Tel: +1 (201) 680-6578
Toll Free (USA): 1 (800) 524-4458
United Therapeutics made its initial public offering on June 17, 1999.
Yes. On September 22, 2009, United Therapeutics completed a 100% stock dividend, effecting a two-for-one stock split. For information regarding the stock split, please click here.
Our annual report as well as other periodic financial reports and SEC filings may be viewed or downloaded from this website. Click here for these reports.
No. United Therapeutics has no immediate plans for such a program.
Our transfer agent will perform any necessary replacements. A fee is likely associated with this service.
Mailing Address:
Computershare
P.O. Box 43006
Providence, RI 02940-3006
Overnight Correspondence Address:
Computershare
P.O. Box 43006
Providence, RI 02940-3006
Website: www.computershare.com/investor
Tel: +1 (201) 680-6578
Toll Free (USA): 1 (800) 524-4458
Yes, click here and follow the instructions.